SCHEMBL5472823

SCHEMBL5472823

O=C(Nc1nccc(-c2ccc(F)cc2)n1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.57
CAMK2D Q13557 2/20 0.56
ABL1 P00519 2/20 0.55
PDGFRB P09619 2/20 0.55
BCR P11274 2/20 0.55
PDGFRA P16234 2/20 0.55
JAK2 O60674 2/20 0.55
LMNA P02545 1/20 0.53
PRKD3 O94806 1/20 0.52
PRKCG P05129 1/20 0.52
PRKCB P05771 1/20 0.52
SRC P12931 1/20 0.52
PRKCA P17252 1/20 0.52
PRKCH P24723 1/20 0.52
PRKCI P41743 1/20 0.52
PRKCE Q02156 1/20 0.52
PRKCQ Q04759 1/20 0.52
PRKCZ Q05513 1/20 0.52
PRKCD Q05655 1/20 0.52
PRKD1 Q15139 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5470852 0.90 ADORA1 (0.69) ADORA1CAMK2DABL1PDGFRBBCR
SCHEMBL5473232 0.86 DYRK1A (0.63) ADORA1CAMK2DABL1PDGFRBBCR
SCHEMBL5472470 0.86 ADORA3 (0.65) ADORA1CAMK2DABL1PDGFRBBCR
SCHEMBL5472892 0.83 JAK2 (0.76) ADORA1CAMK2DJAK2GAAMAPT
SCHEMBL5472976 0.83 PIK3CA (0.59) ADORA1CAMK2DJAK2NPC1RAB9A
SCHEMBL5469085 0.83 ABL1 (0.57) ADORA1CAMK2DABL1PDGFRBBCR
SCHEMBL5462749 0.83 SCN10A (0.54) ADORA1CAMK2DABL1JAK2GSK3B
SCHEMBL5465350 0.83 SIRT2 (0.68) ADORA1CAMK2DABL1PDGFRBBCR
SCHEMBL5470733 0.82 MEN1 (0.56) ADORA1CAMK2DABL1PDGFRBBCR
SCHEMBL5476979 0.82 KMO (0.57) ADORA1ABL1PDGFRBBCRPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070099938-A1 Antistress drug and medical use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-03 US disclosed
EP-1679309-A1 ANTISTRESS DRUG AND MEDICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099938-A1 Antistress drug and medical use thereof NPSR1, MC2R, SRR ADORA1 134/4885CAMK2D 2557/4885ABL1 1671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.